Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Blood-brain barrier
Biotech
AbbVie inks $1.4B Aliada buyout to land ex-J&J Alzheimer's drug
Aliada has in-licensed an Alzheimer’s disease drug candidate from J&J to try to improve on the first generation of anti-amyloid-beta antibodies.
Nick Paul Taylor
Oct 28, 2024 10:00am
Denali reports new method to get ASOs across blood-brain barrier
Aug 14, 2024 2:00pm
A brain parasite has been turned into drug delivery system
Jul 29, 2024 2:55pm
Roche BTK inhibitor may show 'holy grail' of brain penetration
Oct 13, 2023 9:30am
Roche pays $70M for HER2 breast cancer brain metastases prospect
May 9, 2023 6:30am
Blood-brain barrier no barrier to diabetes drugs in Alzheimer's
Oct 27, 2022 3:10pm
